A board certified medical oncologist, Dr. Scholz serves as medical director of Prostate Oncology Specialists Inc. in Marina del Rey. He is also the executive director of the Prostate Cancer Research Institute. Dr. Scholz received his medical degree from Creighton University in Omaha, completed his Internal Medicine internship and Medical Oncology fellowship at the University of Southern California Medical Center. His society memberships include the American Society of Clinical Oncology, American Society of Therapeutic Radiology, American Urologic Associate and European Associate of Urology. Dr. Scholz continues as a primary investigator actively supervising a number of ongoing prostate cancer clinical trials and has authored and coauthored over 90 scholarly articles and abstracts in his area of expertise.
Conditions Dr. Mark Scholz Treats at Marina del Rey Hospital
Insurance Accepted
- Assurant Health
- Aetna
- Cigna
- Coventry Health Care
- HealthNet
- Humana
- Medicare
- Tricare
- United Healthcare
Languages Spoken
- English
- Spanish
Education & Training
Medical Degree
Creighton University
Internship(s)
Internal Medicine, 1983-1984 LAC-USC Medical Center, Los Angeles
Residency(ies)
Internal Medicine, 1984-1986 LAC-USC Medical Center, Los Angeles
Fellowship(s)
Medical Oncology, 1986-1988 Chief Fellow, 1987-1988 LAC-USC Medical Center, Los Angeles
Honors & Awards
Memberships & Affiliations
Fellow of the American College of Physicians
American Medical Association
American Society of Clinical Oncology
American Society for Therapeutic Radiology & Oncology
American Urological Association
California Medical Association
Los Angeles County Medical Association
Publications & Media
-
Excessive PSA or Excessive Biopsy?
Scholz, M. PCRI Insights (October 18, 2011).
-
Prostate Surgery can Lead to Impotency.
TopNews (August 9, 2010). (accessed June 23, 2011).
-
Outcomes of Treatment Vs Observation of Localized Prostate Cancer in Elderly Men.
Journal Jama : the Journal of the American Medical Association
-
Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time off Period.
Journal The Journal of Urology
-
Modified Citrus Pectin (mcp) Increases the Prostate-specific Antigen Doubling Time in Men with Prostate Cancer: a Phase Ii Pilot Study.
Journal Prostate Cancer and Prostatic Diseases
-
Anaemia Associated with Androgen Deprivation in Patients with Prostate Cancer Receiving Combined Hormone Blockade.
Journal British Journal of Urology
